Cerebrospinal fluid examination

2 trials

Sponsors

Yokohama City University, Department of Surgery, Saga University

Conditions

Schizophrenia, mood disorder, dementiabrain/spinal metastases and meningitis of estrogen receptor positive postmenoposal breast cancer

Unknown Phase

The penetration of aromatase inhibitor into the cerebrospinal fluid and the response in brain/spinal metastases and meningitis of estrogen receptor positive breast cancer

RecruitingJPRN-UMIN000013789

Yokohama City University, Department of Surgerybrain/spinal metastases and meningitis of estrogen receptor positive postmenoposal breast cancer

Start: 2014-03-07Target: 30Updated: 2026-06-29

Development of biomarkers for psychiatric disorders (schizophrenia, mood disorders, dementia) by cerebrospinal fluid

Active, not recruitingJPRN-UMIN000038699

Saga UniversitySchizophrenia, mood disorder, dementia

Start: 2018-10-31Target: 50Updated: 2026-06-29